MX2019008260A - Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c. - Google Patents
Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c.Info
- Publication number
- MX2019008260A MX2019008260A MX2019008260A MX2019008260A MX2019008260A MX 2019008260 A MX2019008260 A MX 2019008260A MX 2019008260 A MX2019008260 A MX 2019008260A MX 2019008260 A MX2019008260 A MX 2019008260A MX 2019008260 A MX2019008260 A MX 2019008260A
- Authority
- MX
- Mexico
- Prior art keywords
- renal
- compositions
- methods
- evaluation
- treatment
- Prior art date
Links
- 206010061481 Renal injury Diseases 0.000 title abstract 3
- 102100023705 C-C motif chemokine 14 Human genes 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 title 1
- 208000001647 Renal Insufficiency Diseases 0.000 title 1
- 238000011156 evaluation Methods 0.000 title 1
- 201000006370 kidney failure Diseases 0.000 title 1
- 238000005259 measurement Methods 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 2
- 101710112614 C-C motif chemokine 14 Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/521—Chemokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762445692P | 2017-01-12 | 2017-01-12 | |
| PCT/US2018/013561 WO2018132702A1 (en) | 2017-01-12 | 2018-01-12 | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019008260A true MX2019008260A (es) | 2020-01-27 |
Family
ID=62840533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019008260A MX2019008260A (es) | 2017-01-12 | 2018-01-12 | Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11353465B2 (enExample) |
| EP (2) | EP4063853A1 (enExample) |
| JP (2) | JP2020504157A (enExample) |
| CN (2) | CN110651187A (enExample) |
| AU (1) | AU2018207151B2 (enExample) |
| CA (1) | CA3049444A1 (enExample) |
| MX (1) | MX2019008260A (enExample) |
| WO (1) | WO2018132702A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4063853A1 (en) * | 2017-01-12 | 2022-09-28 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
| EP3732196A4 (en) | 2017-12-28 | 2022-01-05 | Astute Medical, Inc. | ANTIBODIES AND ASSAYS FOR CCL14 |
| US20220236285A1 (en) * | 2019-05-24 | 2022-07-28 | Astute Medical, Inc. | Methods for evaluation and treatment of renal injury based on c-c motif chemokine ligand 14 measurement |
| AU2020300544B2 (en) * | 2019-07-02 | 2024-07-25 | Astute Medical, Inc | Antibodies and assays for CCL14 |
| AU2021381364A1 (en) * | 2020-11-18 | 2023-06-22 | Astute Medical, Inc. | Methods and compositions for treatment of renal injury and renal failure |
| CN113555122B (zh) * | 2021-07-21 | 2024-04-26 | 中南大学湘雅二医院 | 一种重症脓毒症患者一过性和持续性aki的预测模型及其构建方法 |
| AU2023229375A1 (en) * | 2022-03-03 | 2024-09-12 | Astute Medical, Inc. | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6811773B1 (en) * | 1993-12-22 | 2004-11-02 | Human Genome Sciences, Inc. | Human monocyte colony inhibitory factor (M-CIF) polypeptides |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| US20030157573A1 (en) | 2002-02-12 | 2003-08-21 | Orna Mor | Use of Axl receptor for diagnosis and treatment of renal disease |
| US7833732B2 (en) | 2005-07-21 | 2010-11-16 | The John Hopkins University | Acute renal injury |
| EP2479568B1 (en) | 2007-03-26 | 2015-01-07 | Novartis AG | Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| US20110059537A1 (en) | 2007-09-20 | 2011-03-10 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Method for estimating risk of acute kidney injury |
| US9057735B2 (en) | 2008-08-29 | 2015-06-16 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN104020284B (zh) | 2008-10-21 | 2016-08-24 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| EP2462443A4 (en) | 2009-08-07 | 2013-01-30 | Rules Based Medicine Inc | METHODS AND DEVICES FOR DETECTING GLOMERULONEPHRITH AND ASSOCIATED DISORDERS |
| MX2012005210A (es) | 2009-11-07 | 2012-08-03 | Astute Medical Inc | Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal. |
| US20120156701A1 (en) | 2009-12-20 | 2012-06-21 | Joseph Anderberg | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| JP5763098B2 (ja) * | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| DK2666872T3 (en) | 2010-02-05 | 2016-07-25 | Astute Medical Inc | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
| WO2011162821A1 (en) | 2010-06-23 | 2011-12-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN103080743B (zh) | 2010-06-23 | 2015-07-22 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
| US20130203074A1 (en) | 2010-06-23 | 2013-08-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US9410968B2 (en) * | 2011-04-04 | 2016-08-09 | Universiteit Gent | Biomarkers for acute kidney injury |
| ES2721907T3 (es) | 2011-08-26 | 2019-08-06 | Astute Medical Inc | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
| WO2013086359A1 (en) | 2011-12-08 | 2013-06-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2013096740A1 (en) | 2011-12-21 | 2013-06-27 | Alere San Diego Inc. | Methods and compositions for assigning likelihood of chronic kidney disease progression |
| MX388231B (es) | 2014-10-20 | 2025-03-19 | Astute Medical Inc | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. |
| EP4063853A1 (en) | 2017-01-12 | 2022-09-28 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
-
2018
- 2018-01-12 EP EP22155208.6A patent/EP4063853A1/en not_active Withdrawn
- 2018-01-12 CN CN201880012782.7A patent/CN110651187A/zh active Pending
- 2018-01-12 CA CA3049444A patent/CA3049444A1/en active Pending
- 2018-01-12 WO PCT/US2018/013561 patent/WO2018132702A1/en not_active Ceased
- 2018-01-12 EP EP18738815.2A patent/EP3568695A4/en not_active Withdrawn
- 2018-01-12 AU AU2018207151A patent/AU2018207151B2/en active Active
- 2018-01-12 JP JP2019537845A patent/JP2020504157A/ja active Pending
- 2018-01-12 CN CN202111365747.3A patent/CN114088950A/zh active Pending
- 2018-01-12 US US16/475,326 patent/US11353465B2/en active Active
- 2018-01-12 MX MX2019008260A patent/MX2019008260A/es unknown
-
2022
- 2022-03-18 JP JP2022044473A patent/JP2022091846A/ja active Pending
- 2022-05-06 US US17/739,009 patent/US12203944B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11353465B2 (en) | 2022-06-07 |
| EP4063853A1 (en) | 2022-09-28 |
| JP2022091846A (ja) | 2022-06-21 |
| US20230025225A1 (en) | 2023-01-26 |
| CN110651187A (zh) | 2020-01-03 |
| US20190339289A1 (en) | 2019-11-07 |
| CA3049444A1 (en) | 2018-07-19 |
| US12203944B2 (en) | 2025-01-21 |
| EP3568695A4 (en) | 2020-12-16 |
| EP3568695A1 (en) | 2019-11-20 |
| AU2018207151A1 (en) | 2019-07-18 |
| AU2018207151B2 (en) | 2024-02-29 |
| WO2018132702A1 (en) | 2018-07-19 |
| CN114088950A (zh) | 2022-02-25 |
| JP2020504157A (ja) | 2020-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019008260A (es) | Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c. | |
| EP2767833A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP3070474A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2016064877A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX336280B (es) | Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal. | |
| BR112019004075A2 (pt) | métodos para diagnosticar um indivíduo com suspeita de endometriose, para detectar mirna, para diagnosticar um indivíduo que apresenta sintomas de endometriose ou com suspeita de endometriose, para tratar um indivíduo com endometriose, para diagnosticar e tratar um indivíduo com suspeita de endometriose, para diagnosticar endometriose em um indivíduo, para diagnosticar ou prover um prognóstico para endometriose em um indivíduo e para monitorar uma resposta a um tratamento de endometriose em um indivíduo, e, kit. | |
| MX366653B (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| EP3734280A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2017003370A (es) | Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica. | |
| EP4582559A3 (en) | Biomarkers of traumatic brain injury | |
| NZ625423A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP2585827A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
| TR201904386T4 (tr) | Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem. | |
| NZ624614A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| HK1259001A1 (zh) | 癌症的预後和诊断方法 | |
| NZ606124A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2012003168A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. | |
| MX2014000283A (es) | Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. | |
| MX2016009490A (es) | Ensayo novedoso para detectar periostina humana. | |
| PH12018501813A1 (en) | Early detection of hepatocellular carcinoma | |
| WO2021138273A3 (en) | Autoantibodies as biomarkers for autoimmune polyglandular syndrome type 1 | |
| NZ605561A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX348303B (es) | Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico. | |
| WO2018085363A3 (en) | Cd147 detection in diagnostic, prognostic and monitoring methods for multiple myeloma | |
| IN2014MN01759A (enExample) |